MarketsNotableReported
5.2
Argenx trial failure sinks BEL 20 by 2.68%
Le SoirLO·BE·about 22 hours ago
The Brussels Bel 20 index fell up to 3.17%, driven by a sharp decline in arGEN-X, with fourteen components down. Losses were broad-based, including KBC (-1.91%) and Melexis (-2%), while AB InBev (+1.63%) and D'Ieteren (+2.23%) provided partial support. The move reflects sector-specific or company-specific pressure rather than a broad macro shift, though the magnitude suggests notable risk-off sentiment in Belgian equities.